Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
Atherosclerosis
|
August 1, 1993
The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation
T M Bocan, S B Mueller, M J Mazur, et al.
Atherosclerosis
|
August 12, 1998
HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit
T M Bocan, S B Mueller, E Q Brown, et al.
Experimental and Molecular Pathology
|
August 1, 1992
Antiatherosclerotic effects of antioxidants are lesion-specific when evaluated in hypercholesterolemic New Zealand white rabbits
T M Bocan, S B Mueller, E Q Brown, et al.
Atherosclerosis
|
June 28, 2001
The combined effect of inhibiting both ACAT and HMG-CoA reductase may directly induce atherosclerotic lesion regression
T M Bocan, B R Krause, W S Rosebury, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 15, 2000
The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits
T M Bocan, B R Krause, W S Rosebury, et al.
Atherosclerosis
|
December 4, 2001
Molecular sieving and mass spectroscopy reveal enhanced collagen degradation in rabbit atheroma
J Chen, E Kindt, H Hallak, et al.
Circulation
|
May 23, 2001
Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure
J T Peterson, H Hallak, L Johnson, et al.
Biochimica Et Biophysica Acta
|
January 24, 1992
Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitors
T M Bocan, E Ferguson, W McNally, et al.
Atherosclerosis
|
November 1, 1994
Antiatherosclerotic activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cholesterol-fed rabbits: a biochemical and morphological evaluation
T M Bocan, M J Mazur, S B Mueller, et al.
Arteriosclerosis (Dallas, Tex.)
|
September 1, 1989
Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation
G L Cushing, J W Gaubatz, M L Nava, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
Atherosclerosis
|
August 1, 1993
The relationship between the degree of dietary-induced hypercholesterolemia in the rabbit and atherosclerotic lesion formation
T M Bocan, S B Mueller, M J Mazur, et al.
Atherosclerosis
|
August 12, 1998
HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit
T M Bocan, S B Mueller, E Q Brown, et al.
Experimental and Molecular Pathology
|
August 1, 1992
Antiatherosclerotic effects of antioxidants are lesion-specific when evaluated in hypercholesterolemic New Zealand white rabbits
T M Bocan, S B Mueller, E Q Brown, et al.
Atherosclerosis
|
June 28, 2001
The combined effect of inhibiting both ACAT and HMG-CoA reductase may directly induce atherosclerotic lesion regression
T M Bocan, B R Krause, W S Rosebury, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
January 15, 2000
The ACAT inhibitor avasimibe reduces macrophages and matrix metalloproteinase expression in atherosclerotic lesions of hypercholesterolemic rabbits
T M Bocan, B R Krause, W S Rosebury, et al.
Atherosclerosis
|
December 4, 2001
Molecular sieving and mass spectroscopy reveal enhanced collagen degradation in rabbit atheroma
J Chen, E Kindt, H Hallak, et al.
Circulation
|
May 23, 2001
Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure
J T Peterson, H Hallak, L Johnson, et al.
Biochimica Et Biophysica Acta
|
January 24, 1992
Hepatic and nonhepatic sterol synthesis and tissue distribution following administration of a liver selective HMG-CoA reductase inhibitor, CI-981: comparison with selected HMG-CoA reductase inhibitors
T M Bocan, E Ferguson, W McNally, et al.
Atherosclerosis
|
November 1, 1994
Antiatherosclerotic activity of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase in cholesterol-fed rabbits: a biochemical and morphological evaluation
T M Bocan, M J Mazur, S B Mueller, et al.
Arteriosclerosis (Dallas, Tex.)
|
September 1, 1989
Quantitation and localization of apolipoproteins [a] and B in coronary artery bypass vein grafts resected at re-operation
G L Cushing, J W Gaubatz, M L Nava, et al.
Page
of 4